It is important to be aware of prostate cancer in order to get the best diagnosis and treatment. Here are 7 myths busted by an expert.
Prostate cancer is the second most common type of cancer in men and the sixth most fatal cause of death worldwide. Statistics over the past few decades have shown that prostate cancer incidence is lower in Asian men than it was among African, African-American, and Caucasian people. However, this trend is definitely on the rise.
Over the past two decades, significant advances have been made in the treatment of prostate carcinoma. These include the development of new drugs (cytotoxic drugs and antiandrogens as well as immunotherapeutic drugs) that can be used for better control. Radiotherapy and surgery have been improved to provide higher rates of cancer cure and control with fewer complications and longer-term morbidity.
Despite all the advances in prostate cancer research, there are still many misconceptions. This disease can be overcome if there is a better understanding.
Here are some myths about prostate cancer and the facts that we need to know.
Myth 1: I do not have prostate cancer as I do not have any symptoms.
It can be difficult to detect prostate cancer in its early stages. The majority of prostate cancer cases in the early stages are not symptomatic and develop into symptoms in later stages. Patients who are completely symptomatic have experienced complications such as bone fractures from metastatic cancer. It is important to be evaluated the risk factors such as positive family history and obesity.
Myth 2: Screening is not required as prostate cancer is rare in India
Screening for prostate cancer is done by regularly checking serum PSA levels in asymptomatic patients. Although this practice is controversial among urologists, it has been widely used in western countries. It may also be relevant to our country in recent years because of the increasing incidence of prostate cancer. Screening allows us to detect the disease early and provide curative treatment with lower morbidity.
Myth 3: A high PSA is certainly because of prostate cancer
PSA, or Prostate-Specific Antigen, is specific for prostate diseases but not cancer. PSA levels increase not only in this type of cancer but also in prostatitis and prostatic abscess.
Myth 4: Risk of cancer is high in larger prostate glands
Benign prostate hyperplasia is a benign, non-cancerous, enlargement of your prostate. It is much more common than prostrate carcinoma. There is no clear correlation between the size and risk of developing cancer. The majority of large prostate glands, however, are benign.
Myth 5: Treatment for prostate cancer is complicated and associated with permanent disability and suffering.
This disease has seen significant improvements in its treatment. Both the disease and its treatment have been made more comfortable. Additionally, survival rates for cancer have been improved. Therefore, it is important to consider treatment at every stage of the disease.
Myth 6: I read that prostate cancer are mild and do not need to be treated
The majority of cases of prostate cancer in India (over 75%) are found in advanced stages. This is after the disease has spread beyond the prostate gland. Advanced cancers can cause complications such as bone fractures, kidney disease, and swelling of the limbs. It is important to diagnose prostate cancer early, regardless of its stage. The chances of a cure increase if the disease is localized to the prostate.
Myth 7: It is futile to treat advanced cancers as most men die soon regardless of treatment.
Prostate cancer is different from other types of cancer. It can be treated with multiple modalities and has a high survival rate. The quality of life for advanced prostate cancer patients can be improved by hormonal therapy. Advanced prostate cancer should be treated.